Ombre is a provider of a microbiome testing kit designed to incorporate personalized probiotics and microbiome testing.
Ombre has raised $4.0M in total funding. The most recent round was Seed. The last funding was announced in February 2022.
Ombre's investors include Plug and Play, Abstract, TMV, Relevance Ventures (formerly Relevance Capital), PivotNorth Capital.
Ombre is headquartered in San Francisco, United States.
Ombre is a provider of a microbiome testing kit designed to incorporate personalized probiotics and microbiome testing.
Ombre is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ombre — Funding & Investors." VCBacked, February 15, 2022, https://www.vcbacked.co/company/ombre. Accessed July 19, 2026.
VCBacked. (2022). Ombre — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/ombre
{{cite web |title=Ombre — Funding & Investors |url=https://www.vcbacked.co/company/ombre |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated